MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.330
-0.010 (-0.75%)
Jul 31, 2026, 4:00 PM EDT - Market closed

MediciNova Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.60.41-1-4.04
Revenue Growth
------
Gross Profit
0.050.03-1-4.04
Operating Income
-12.92-13.28-12.68-9.9-14.63-10.22
Net Income
-11.72-12-11.05-8.57-14.07-10.13
Earnings Per Share
-0.23-0.24-0.23-0.17-0.29-0.21
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
27.3330.8140.365158.4971.43
Total Debt
0.170.190.190.220.160.13
Net Cash (Debt)
27.1630.6140.1750.7858.3371.3
Net Cash Growth
-25.34%-23.79%-20.91%-12.94%-18.19%19.13%
Net Cash Per Share
0.550.620.821.041.191.47

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.5-9.81-10.64-7.43-12.91-9.38
Capital Expenditures
--0-0-0.02-0.01-0.03
Free Cash Flow
-9.5-9.81-10.64-7.45-12.92-9.41
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
8.03%7.58%-100.00%-100.00%
Operating Margin
-2164.84%-3242.47%--990.03%--253.02%
Pretax Margin
-1963.34%-2927.32%--856.85%--250.94%
Profit Margin
-1964.35%-2928.78%--857.15%--251.00%
FCF Margin
-1591.68%-2395.41%--745.23%--233.07%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-153.51153.51153.51153.51153.51
PS Ratio
109.72157.40-73.57-32.55